REFERENCES
- Del Vecchio G, Shettini F, Piacente L, De Santis A, Giordano P, De Mattia D. Effects of deferiprone on immune status and cytokine pattern in thalassemia major. Acta Haematol 2002; 108(3)144–149
- Pradhan V, Badakere S, Ghosh K. Antihistone and other autoantibodies in β-thalassemia major patients receiving iron chelators. Acta Haematol 2003; 109(1)35–39
- Zafeiriou D, Koussi A, Tsantali C, Kontopoulos E, Augoustidou P, Tsoubaris D, Athanassiou M. Neurophysiologic evaluation of long term desferrioxamine therapy in β-thalassemia patients. Pediatr Neurol 1998; 18(5)420–424
- Loebstein R, Dala I, Nisbet-Brown E, Berkovitch M, Meydan N, Andrews D, Loubser M, Koren G, Roifman C, Olivieri N. Immune function in patients with β thalassaemia receiving the orally active iron-chelating agent deferiprone. Br J Haematol 1997; 98(3)597–600
- Levine JE, Cohen A, MacQueen M, Martin M, Giardina PJ. Sensorimotor neurotoxicity associated with high dose deferoxamine treatment. J Pediatr Hematol Oncol 1997; 19(2)139–141
- Athanassiou-Metaxa M, Tzimouli V, Economou M, Taparkou A, Tourkantoni N, Kanakoudi-Tsakalidou F. Immune status of thalassemic patients receiving deferiprone or combined deferiprone and desferrioxamine chelation treatment. Acta Haematol 2003; 110(1)224–226
- Mehta J, Singhal S, Revankar R, Walvalkar A, Chablani A, Mehta BC. Fetal systemic lupus erythematosus in patient taking oral iron chelator L1. Lancet 1991; 337(8736)298
- Mehta J, Singhal S, Mehta BC. Oral iron chelator L1 and autoimmunity. Blood 1993; 81(1)1970–1971
- Berdoukas V, Bentley P, Frost H, Schnebli HP. Toxicity of oral iron chelator L1. Lancet 1993; 341(8852)1088
- Zafeiriou DI, Economou M, Athanassiou-Metaxa M. Neurological complications in β-thalassemia. Brain Dev 2006; 28(8)477–481
- Galanello R, Kattamis A, Piga A, Fischer R, Leoni G, Ladis V, Voi V, Lund U, Tricta F. A prospective randomized controlled trial on the safety and efficacy of alternating deferoxamine and deferiprone in the treatment of iron overload in patients with thalassemia. Haematologica. 2006; 91(2)1241–1243